Suchergebnisse - "Santoro, Armando"

PubPharm (898)

1

Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer : clinical trials, current impact, and future directions

enthalten in: Critical reviews in oncology/hematology | 2024

von Gerosa, R. | De Sanctis, R. | Jacobs, F. | +10

2

A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma

enthalten in: JHEP reports : innovation in hepatology | 2024

von Santoro, A. | Assenat, E. | Yau, T. | +12

3

Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma

enthalten in: Bone marrow transplantation | 2024

von De Philippis, C. | Zucchinetti, C. | Mannina, D. | +10

4

Fruquintinib as new treatment option in metastatic colorectal cancer patients : is there an optimal sequence?

enthalten in: Expert opinion on pharmacotherapy | 2024

von Stucchi, E. | Bartolini, M. | Airoldi, M. | +6

5

Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non-Small Cell Lung Cancer

enthalten in: Cancer research | 2024

von Rigamonti, A. | Viatore, M. | Polidori, R. | +18

6

Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma

enthalten in: Blood advances | 2024

von Zinzani, P. | Salles, G. | Moskowitz, A. | +17

7

Brentuximab Vedotin and Chemotherapy in Relapsed/Refractory Hodgkin Lymphoma : a Propensity Score Matched Analysis

enthalten in: Blood advances | 2024

von Driessen, J. | de Wit, F. | Herrera, A. | +14

8

Response to first-line pembrolizumab in metastatic KRAS-mutated non-small-cell lung cancer

enthalten in: Future oncology (London, England) | 2024

von Rossi, S. | Pagliaro, A. | Finocchiaro, G. | +8

9

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting : final analysis of LUCY

enthalten in: Breast cancer research and treatment | 2024

von Balmaña, J. | Fasching, P. | Couch, F. | +123

10

Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer

enthalten in: Biomedicines | 2024

von Saltalamacchia, G. | Torrisi, R. | De Sanctis, R. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[90]